RAM
AXSM icon

Readystate Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Readystate Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.21M Buy
+33,554
New +$7.28M 0.28% 78
2025
Q4 		– Sell
-17,860
Closed -$2.17M – 394
2025
Q3 		$2.17M Sell
17,860
-76,711
-81% -$8.64M 0.09% 144
2025
Q2 		$9.87M Buy
94,571
+35,018
+59% +$3.71M 0.3% 67
2025
Q1 		$6.95M Buy
+59,553
New +$6.78M 0.23% 78

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Readystate Asset Management's AXSM Position: Q2 2026 in Review

Readystate Asset Management opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 33,554 shares worth $8.21M. The stake represents 0.28% of the portfolio and ranks #78 among its holdings. This is a return to the name: Readystate Asset Management previously reported a position in AXSM as recently as Q3 2025.

Readystate Asset Management first reported a position in AXSM in Q1 2025 and has held it in 4 quarters since. The position peaked at $9.87M in Q2 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Readystate Asset Management held 33,554 shares of Axsome Therapeutics worth $8.21M as of Q2 2026.
  • Axsome Therapeutics was a new Readystate Asset Management position in Q2 2026.
  • Axsome Therapeutics made up 0.28% of Readystate Asset Management's portfolio in Q2 2026, its #78 holding.
  • Readystate Asset Management first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Readystate Asset Management's Axsome Therapeutics position peaked at $9.87M in Q2 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.